Valcyte works by preventing the spread of cytomegalovirus (CMV) disease, or slowing the growth of CMV. It is indicated for the treatment of CMV retinitis in adult patients with acquired immunodeficiency syndrome (AIDS), and the prevention of CMV disease in adult and paediatric solid organ transplant patients who are at risk of infection.

M-PK-00001196